Editing Mood stabilizer (section)

===Mineral===
; [[Lithium (medication)|Lithium]]
: Lithium is the "classic" mood stabilizer, the first to be approved by the US FDA, and still popular in treatment. [[Therapeutic drug monitoring]] is required to ensure lithium levels remain in the therapeutic range: 0.6 to 0.8 or 0.8&ndash;1.2 [[Equivalent (chemistry)|mEq]]/L (or millimolar). Signs and symptoms of toxicity include nausea, vomiting, diarrhea, and [[ataxia]].<ref name=pmid_18789369>{{Cite journal | last1 = Marmol | first1 = F. | title = Lithium: Bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium | doi = 10.1016/j.pnpbp.2008.08.012 | journal = Progress in Neuro-Psychopharmacology and Biological Psychiatry | volume = 32 | issue = 8 | pages = 1761–1771 | year = 2008 | pmid = 18789369 | s2cid = 25861243 }}</ref> The most common side effects are lethargy and weight gain (up to {{convert|2|kg|lb}}).<ref name="Malhi_2013b">{{cite journal |title=Safe and effective use of lithium |journal=Australian Prescriber |volume=36 |pages=18–21 |doi=10.18773/austprescr.2013.008 |year=2013 | vauthors = Malhi GS, Tanious M, Bargh D, Das P, Berk M |doi-access=free}}</ref> The less common side effects of using lithium are blurred vision, a slight tremble in the hands, and a feeling of being mildly ill. In general, these side effects occur in the first few weeks after commencing lithium treatment. These symptoms can often be improved by lowering the dose.<ref>Kozier, B et al. (2008). Fundamentals Of Nursing, Concepts, Process, and Practice. London: Pearson Education. p. 189.</ref>